Home›The Treatise›Chapters›Chapter 19
Tratado de Cirurgia da Coluna Vertebral
SECTION 3 • Traumatic Spine Injuries
Chapter19

Spinal Cord Injury and Traumatic Myelopathy

Vancouver: Vialle EN, Zanon M📖 Pages: 251-258
Full reading of this chapter is available exclusively in the printed edition of the Treatise.
Sec. 3Traumatic Spine Injuries
Cap. 19Clinical Chapter
2authors
Português
Español
English
Referênciasscientific citations
📑

Chapter Summary

• Context: Traumatic spinal cord injury (SCI) represents a devastating medical and surgical emergency combining mechanical disruption of neural pathways, acute vertebral instability, and profound systemic autonomic dysregulation. Pathophysiologically, SCI evolves in a two-phase cascade: the primary injury consists of immediate mechanical tissue disruption, axonal shearing, petechial microvascular hemorrhage, and localized ischemia at the moment of impact; this triggers a destructive secondary injury cascade evolving over subsequent hours and days, characterized by extensive microvascular vasospasm, blood-spinal cord barrier breakdown, cytotoxic and vasogenic edema, glutamate excitotoxicity, free radical lipid peroxidation, neuroinflammation, oligodendrocyte apoptosis, and expanding secondary ischemia. Clinical presentation ranges from complete transection (ASIA A) to incomplete spinal cord syndromes: Central Cord syndrome (greater motor weakness in upper than lower extremities), Brown-Séquard syndrome (ipsilateral motor/proprioceptive loss with contralateral pain/temperature loss), Anterior Cord syndrome (loss of motor and spinothalamic function with preserved dorsal column proprioception), Conus Medullaris syndrome, and Cauda Equina syndrome. Management requires immediate systemic neuroprotection: maintaining Mean Arterial Pressure (MAP >= 85–90 mmHg for 5–7 days), avoiding hypoxia (PaO2 > 60 mmHg), early surgical decompression and realignment (<24 hours, ideally <12 hours according to the STASCIS trial), and preventing systemic complications (neurogenic shock, autonomic dysreflexia, venous thromboembolism, neurogenic bladder/bowel, and pressure ulcers).
• Chapter Objective: To present current evidence-based principles for the evaluation, neuroprotection, surgical decompression, and comprehensive acute management of traumatic spinal cord injury. The reader should be able to understand the primary mechanical insult and secondary biochemical injury cascades; perform and document standardized neurological examinations according to ISNCSCI/ASIA standards; differentiate incomplete cord syndromes; execute hemodynamic optimization protocols (MAP targets); select candidates for urgent surgical decompression; and manage acute systemic complications and neurogenic shock.
• Primary Injury and the Secondary Pathophysiological CascadePrimary injury occurs at impact via contusion, compression, distraction, or laceration of neural tissue and microvasculature. Secondary injury develops over hours to weeks: 1) Vascular phase: petechial central gray matter hemorrhage, loss of autoregulation, vasospasm, and microthrombosis causing expanding ischemia; 2) Cellular phase: energy failure (ATP depletion), massive glutamate release, pathological intracellular calcium influx, and free radical generation (lipid peroxidation); 3) Inflammatory and apoptotic phase: neutrophil and macrophage infiltration, cytokine release (TNF-alpha, IL-1beta), and programmed cell death (apoptosis) of oligodendrocytes causing post-traumatic demyelination and secondary cord cavitation.
• Standardized Neurological Assessment (ISNCSCI/ASIA)Baseline examination must follow the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) as soon as the patient is alert and resuscitated: 1) Motor examination: test 10 key muscle groups bilaterally (MRC scale 0–5, total score 100); 2) Sensory examination: test 28 dermatomes bilaterally for pinprick and light touch (total score 112 each); 3) Anorectal examination: assess voluntary anal contraction (VAC, S4–S5 motor) and deep anal pressure (DAP, S4–S5 sensory). Define the Motor Level, Sensory Level, and Neurological Level of Injury (NLI). Classify using the ASIA Impairment Scale (AIS): AIS A (Complete, no sacral sparing S4–S5); AIS B (Sensory Incomplete, sensory but no motor preserved below NLI including S4–S5); AIS C (Motor Incomplete, more than half of key muscles below NLI have muscle grade <3); AIS D (Motor Incomplete, at least half of key muscles below NLI have muscle grade >=3); AIS E (Normal).
• Incomplete Cord Syndromes and Neurogenic ShockIncomplete syndromes feature specific tract injury patterns: 1) Central Cord Syndrome: hyperextension injury in stenotic cervical spines, causing disproportionately greater upper extremity weakness (distal hand intrinsics) than lower extremity impairment, with variable sensory loss; 2) Brown-Séquard Syndrome: hemisection from penetrating or burst trauma, causing ipsilateral loss of motor function and proprioception/vibration with contralateral loss of pain and temperature 1–2 segments below injury; 3) Anterior Cord Syndrome: flexion-compression injury with anterior spinal artery occlusion, causing complete bilateral motor paralysis and loss of pain/temperature with preserved dorsal column proprioception (worst recovery prognosis). Neurogenic shock (cervical/high-thoracic T6 and above injury) is characterized by the triad of hypotension, bradycardia, and peripheral vasodilation due to loss of sympathetic tone, distinct from spinal shock (transient loss of all spinal reflex activity and flaccidity below injury level, ending when the bulbocavernosus reflex returns).
• Hemodynamic Neuroprotection and Surgical Timing (STASCIS)Hemodynamic management aims to prevent secondary ischemic cord injury: maintain Mean Arterial Pressure (MAP) between 85 and 90 mmHg for 5 to 7 days in the ICU using volume resuscitation and vasopressors with combined inotropic and vasoconstrictive properties (norepinephrine, dopamine, or epinephrine; avoid pure vasoconstrictors like phenylephrine that worsen bradycardia). Surgical decompression and rigid stabilization within 24 hours (and ideally within 12 hours) of injury—supported by the landmark STASCIS prospective trial and subsequent pooled analyses—significantly increases the likelihood of >=2 AIS grade neurological recovery compared to delayed decompression (>24 hours).
• Pharmacotherapy, Complications, and Acute RehabilitationHigh-dose methylprednisolone (NASCIS protocol) remains highly controversial; modern international guidelines (AANS/CNS and AO Spine) consider it a treatment option rather than a standard of care due to high risks of severe pneumonia, sepsis, GI bleeding, and death. Systemic management includes: early venous thromboembolism prophylaxis (LMWH started 24–48 hours post-injury/surgery and mechanical compression), aggressive pulmonary toilet and mechanical ventilation weaning, clean intermittent catheterization to avoid bladder distension and dysreflexia, bowel protocols, and pressure-relieving air mattresses.
• Clinical Application: In the emergency department, when a patient presents with cervical trauma and acute quadriparesis, immediately obtain emergent whole-spine CT and urgent MRI to demonstrate compressive bone fragments, disc herniation, or facet subluxation. Simultaneously initiate invasive arterial line monitoring and titrate norepinephrine to maintain MAP between 85 and 90 mmHg. In patients with bilateral facet dislocations, prompt closed skeletal traction with Gardner-Wells tongs (under conscious sedation with continuous neurological monitoring) or emergent operative open reduction within hours restores canal dimensions and cord perfusion. Transfer the patient to the operating room immediately for definitive anterior, posterior, or circumferential decompression and instrumented fusion (<12–24 hours). In patients with high lesions (T6 and above), remain vigilant for autonomic dysreflexia (paroxysmal severe hypertension, throbbing headache, bradycardia, profuse sweating above lesion triggered by bladder distension or fecal impaction), treating it by sitting the patient upright and rapidly emptying the bladder or bowel.
🏷️

Keywords

Preferred DeCS/MeSH Descriptors:
Spinal Cord InjuriesTrauma, Nervous SystemParaplegiaQuadriplegiaNeuroprotectionSpinal FusionIntensive Care UnitsDecompression, Surgical
⭐

Why this chapter matters

Primary mechanical damage occurs in milliseconds, but the biological fate of marginal, penumbral spinal cord axons is decided in the subsequent hours and days. Overlooking hypotension, delaying operative decompression beyond 24 hours, or failing to differentiate neurogenic shock from hypovolemia leads to permanent paralysis. This chapter equips the clinician with actionable neuroprotective protocols, standardized classification tools, and surgical timing principles to optimize recovery and prevent secondary systemic morbidity.

“Traumatic spinal cord injury management requires rapid, aggressive neuroprotection to arrest the secondary injury cascade. Integrating emergent surgical decompression and spinal stabilization within 12 to 24 hours (STASCIS), maintaining intensive hemodynamic augmentation (MAP >= 85–90 mmHg for 5–7 days), performing rigorous ISNCSCI/ASIA evaluations, and executing systematic multi-organ intensive care are the cornerstones of maximizing neurological recovery.”
✨

Chapter Highlights

🌐
Card 1 — Core Concept
The Two Phases of Spinal Cord Injury

Primary mechanical disruption triggers a secondary biochemical cascade (ischemia, excitotoxicity, calcium influx, apoptosis) expanding over hours and days. Intensive neuroprotection aims to rescue penumbral axons through early decompression and perfusion optimization.

🩺
Card 2 — Clinical Decision
Early Surgical Decompression (<24h, Ideally <12h)

The STASCIS prospective trial demonstrated that early surgical decompression within 24 hours (and ideally <12 hours) significantly improves neurological recovery (>=2 AIS grade improvement) compared to delayed surgery in acute spinal cord injury.

📐
Card 3 — Key Pearl / Warning
Maintain MAP 85–90 mmHg for 5–7 Days

Autoregulation of spinal cord blood flow is lost after trauma. Maintain Mean Arterial Pressure (MAP) >= 85–90 mmHg for 5 to 7 days in the ICU using volume and norepinephrine to prevent secondary spinal cord ischemia. Recognize neurogenic shock (hypotension + bradycardia).

📑

How to Cite this Chapter (Vancouver Format)

Official bibliographic indexing and citation guidelines
📖 Pages: 251-258Vancouver Style
Authors (Vancouver):Vialle EN, Zanon M

Vialle EN, Zanon M. Trauma raquimedular. In: Pudles E, Defino H, Risso M, editors. Tratado de Cirurgia da Coluna Vertebral (Treatise of Spine Surgery). 1st ed. Rio de Janeiro: Dilivros Editora; 2026. p. 251-258.

ISBN: 978-85-8053-292-0 • 1.ª Edição • Dilivros Editora
📚

Bibliographic References

1. Simeonova I, Sandner B, et al. Neural stem cell transplantation for spinal cord repair. In: Fehlings MG, Harrop JS, editors. AOSpine master series. Vol. 10. Stuttgart: Thieme; 2017. p. 111-123. doi:10.1055/b-0036-137999.
2. Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev. 2012;(1):CD001046. doi:10.1002/14651858.CD001046.pub2.
3. Schouten R, Albert T, et al. The spine-injured patient: initial assessment and emergency treatment. J Am Acad Orthop Surg. 2012 Jun;20(6):336-46. doi:10.5435/JAAOS-20-06-336. PMID:22661563.
4. Nouri A, Fehlings MG, et al. The timing of management of spinal cord injuries. In: Browner BD, Jupiter JB, Levine AM, Trafton PG, editors. Skeletal trauma: basic science, management, and reconstruction. 5th ed. Philadelphia: Saunders; 2014. p. 769-790.
5. Jazayeri SB, Maroufi SF, et al. Incidence of traumatic spinal cord injury worldwide: a systematic review, data integration, and update. World Neurosurg X. 2023 Feb 1;18:100171. doi:10.1016/j.wnsx.2023.100171. PMID:36910686.
6. Vaccaro AR, Harrop JS, et al. Prehospital and emergency room management, as well as timing of treatment. In: Eismont FJ, Bell GR, editors. Spine: core knowledge in orthopaedics. Philadelphia: Mosby Elsevier; 2010. p. 275-289.
7. Catapano JS, Hawryluk GWJ, et al. Acute non-operative management of traumatic spinal cord injury: state of the art. In: Fehlings MG, Harrop JS, editors. AOSpine master series. Vol. 5. Stuttgart: Thieme; 2017. p. 55-72. doi:10.1055/b-0036-137994.
8. Kirshblum SC, Burns SP, et al. International standards for neurological classification of spinal cord injury: revised 2011. J Spinal Cord Med. 2011 Nov;34(6):535-46. doi:10.1179/204577211X13207446293695. PMID:22330108.
9. Zhang L-X, Yin Y-M, et al. Grafted bone marrow stromal cells: a contributor to glial repair after spinal cord injury. The Neuroscientist. 2014;21(3):277-289. doi:10.1177/1073858414532171.
10. Wilson JR, Fehlings MG. Riluzole for acute traumatic spinal cord injury: a promising neuroprotective treatment strategy. World Neurosurg. 2014 May-Jun;81(5-6):825-9. doi:10.1016/j.wneu.2013.01.001. PMID:23295632.
11. Wilson JR, Cadotte DW, et al. Clinical predictors of neurological outcome, functional status, and survival after traumatic spinal cord injury: a systematic review. J Neurosurg Spine. 2012 Sep;17(1 Suppl):11-26. doi:10.3171/2012.4.AOSPINE1245. PMID:22985366.
12. Fehlings MG, Vaccaro A, et al. Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS One. 2012;7(2):e32037. doi:10.1371/journal.pone.0032037. PMID:22384132.
13. Kamiya K, Koda M, et al. Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control. Eur Spine J. 2015 May;24(5):963-7. doi:10.1007/s00586-014-3373-0. PMID:24961222.
14. Casha S, Zygun D, et al. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain. 2012 Apr;135(Pt 4):1224-36. doi:10.1093/brain/aws072. PMID:22505632.
15. Grossman RG, Fehlings MG, et al. A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma. 2014 Feb 1;31(3):239-55. doi:10.1089/neu.2013.2969. PMID:23859435.
16. Dasari VR, Veeravalli KK, et al. Mesenchymal stem cells in the treatment of spinal cord injuries: a review. World J Stem Cells. 2014 Apr 26;6(2):120-33. doi:10.4252/wjsc.v6.i2.120. PMID:24772239.
17. Ramer LM, Ramer MS, et al. Restoring function after spinal cord injury: towards clinical translation of experimental strategies. Lancet Neurol. 2014 Dec;13(12):1241-56. doi:10.1016/S1474-4422(14)70144-9. PMID:25453463.
18. Jazayeri SB, Maroufi SF, et al. Incidence of traumatic spinal cord injury worldwide: a systematic review, data integration, and update. World Neurosurg X. 2023 Feb 1;18:100171. doi:10.1016/j.wnsx.2023.100171. PMID:36910686.
19. Hubertus V, Badhiwala JH, et al. AO Spine clinical practice recommendations for the surgical management of acute traumatic spinal cord injury: contemporary concepts. Global Spine J. 2025 Jun 8:21925682251350941. doi:10.1177/21925682251350941. PMID:40483581.
20. Aarabi B, Olexa J, et al. Extent of spinal cord decompression in motor complete American Spinal Injury Association Impairment Scale grades A and B traumatic spinal cord injury patients: postoperative magnetic resonance imaging analysis of standard operative approaches. J Neurotrauma. 2019;36:862-876. doi:10.1089/neu.2018.5834.
Episode 06 – Early-Onset Scoliosis
Scheduled Premiere
Exclusive Premiere • Wednesday, October 07 at 9:00 PM (BRT)
Wednesday, October 07 at 9:00 PM (BRT)
The live countdown will be activated on the eve of the premiere.

The full videocast will premiere automatically in this player on Wednesday, 10/07 at 6:00 PM (BRT).

Also premiering on Spotify
Treatise in Debate

Official videocast derived from the treatise chapters.

Episode 06 – Early-Onset Scoliosis

Lungs and the Growing Spine: thoracic development, C-EOS classification, and growth-friendly surgical techniques